Metal–organic frameworks (MOFs) have dramatically
changed
the fundamentals of drug delivery, catalysis, and gas storage as a
result of their porous geometry, controlled architecture, and ease
of postsynthetic modification. However, the biomedical applications
of MOFs still remain a less explored area due to the constraints associated
with handling, utilizing, and site-specific delivery. The major drawbacks
associated with the synthesis of nano-MOFs are related to the lack
of control over particle size and inhomogeneous dispersion during
doping. Therefore, a smart strategy for the in situ growth of a nano-metal–organic framework (nMOF) has been
devised to incorporate it into a biocompatible polyacrylamide/starch
hydrogel (PSH) composite for therapeutic applications. In this study,
the post-treatment of zinc metal ion cross-linked PSH with the ligand
solution generated the nZIF-8@PAM/starch composites (nZIF-8, nano-zeolitic
imidazolate framework-8). The ZIF-8 nanocrystals thus formed have
been found to be evenly dispersed throughout the composites. This
newly designed nanoarchitectonics of an MOF hydrogel was found to
be self-adhesive, which also exhibited improved mechanical strength,
a viscoelastic nature, and a pH-responsive behavior. Taking advantage
of these properties, it has been utilized as a sustained-release drug
delivery platform for a potential photosensitizer drug (Rose Bengal).
The drug was initially diffused into the in situ hydrogel,
and then the entire scaffold was analyzed for its potential in photodynamic
therapy against bacterial strains such as E. coli and B. megaterium. The Rose Bengal loaded nano-MOF
hydrogel composite exhibited remarkable IC50 values within
the range of 7.37 ± 0.04 and 0.51 ± 0.05 μg/mL for E. coli and B. megaterium. Further, reactive
oxygen species (ROS) directed antimicrobial potential was validated
using a fluorescence-based assay. This smart in situ nanoarchitectonics hydrogel platform can also serve as a potential
biomaterial for topical treatment including wound healing, lesions,
and melanoma.